These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 10210023
1. The efficacy of felbamate as add-on therapy to valproic acid in the Lennox-Gastaut syndrome. Siegel H, Kelley K, Stertz B, Reeves-Tyer P, Flamini R, Malow B, Gaillard WD, Ko D, Theodore WH. Epilepsy Res; 1999 Apr; 34(2-3):91-7. PubMed ID: 10210023 [Abstract] [Full Text] [Related]
2. Changes of the EEG paroxysmal pattern during felbamate therapy in Lennox-Gastaut syndrome: a case report. Marciani MG, Spanedda F, Placidi F, Bassetti MA, Romigi A, Mattia D. Int J Neurosci; 1998 Sep; 95(3-4):247-53. PubMed ID: 9777442 [Abstract] [Full Text] [Related]
3. Felbamate in the treatment of Lennox-Gastaut syndrome: results of a 12-month open-label study following a randomized clinical trial. Dodson WE. Epilepsia; 1993 Sep; 34 Suppl 7():S18-24. PubMed ID: 8243374 [Abstract] [Full Text] [Related]
4. Felbamate in the treatment of Lennox-Gastaut syndrome. Jensen PK. Epilepsia; 1994 Sep; 35 Suppl 5():S54-7. PubMed ID: 8039473 [Abstract] [Full Text] [Related]
5. Isobolographic and subthreshold analysis of interactions among felbamate and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice. Borowicz KK, Luszczki JJ, Czuczwar SJ. Epilepsia; 2004 Oct; 45(10):1176-83. PubMed ID: 15461671 [Abstract] [Full Text] [Related]
6. Felbamate in the treatment of refractory partial-onset seizures. Jensen PK. Epilepsia; 1993 Oct; 34 Suppl 7():S25-9. PubMed ID: 8243375 [Abstract] [Full Text] [Related]
7. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). Felbamate Study Group in Lennox-Gastaut Syndrome. N Engl J Med; 1993 Jan 07; 328(1):29-33. PubMed ID: 8347179 [Abstract] [Full Text] [Related]
8. Felbamate monotherapy for partial-onset seizures: an active-control trial. Faught E, Sachdeo RC, Remler MP, Chayasirisobhon S, Iragui-Madoz VJ, Ramsay RE, Sutula TP, Kanner A, Harner RN, Kuzniecky R. Neurology; 1993 Apr 07; 43(4):688-92. PubMed ID: 8469323 [Abstract] [Full Text] [Related]
12. Efficacy and safety of felbamate in children with refractory epilepsy. Heyman E, Levin N, Lahat E, Epstein O, Gandelman-Marton R. Eur J Paediatr Neurol; 2014 Nov 07; 18(6):658-62. PubMed ID: 24906615 [Abstract] [Full Text] [Related]
16. [Felbamate: perspectives for new antiepileptic treatment]. Pérez-Miranda J, Aguirre J, Parrilla JL, Pérez Miranda M. Rev Neurol; 1995 Jun 07; 23(124):1220-5. PubMed ID: 8556622 [Abstract] [Full Text] [Related]
17. Felbamate in the treatment of partial-onset seizures. Bourgeois BF. Epilepsia; 1994 Jun 07; 35 Suppl 5():S58-61. PubMed ID: 8039474 [Abstract] [Full Text] [Related]
18. Felbamate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy. Palmer KJ, McTavish D. Drugs; 1993 Jun 07; 45(6):1041-1065. PubMed ID: 7691493 [Abstract] [Full Text] [Related]
19. Felbamate pharmacology and use in epilepsy. Burdette DE, Sackellares JC. Clin Neuropharmacol; 1994 Oct 07; 17(5):389-402. PubMed ID: 9316688 [Abstract] [Full Text] [Related]